Home
>
National Drug Code (NDC)
>
Tricode
Tricode - 60575-414-16 - (Codeine Phosphate, Guaifenesin, Pseudoephedrine Hydrochloride)
Drug Information of Tricode
| Product NDC: | 60575-414 |
| Proprietary Name: | Tricode |
| Non Proprietary Name: | Codeine Phosphate, Guaifenesin, Pseudoephedrine Hydrochloride |
| Active Ingredient(s): | 8; 200; 30 mg/5mL; mg/5mL; mg/5mL & nbsp; Codeine Phosphate, Guaifenesin, Pseudoephedrine Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Tricode
| Product NDC: | 60575-414 |
| Labeler Name: | Respa Pharmaceuticals, Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part341 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20110620 |
Package Information of Tricode
| Package NDC: | 60575-414-16 |
| Package Description: | 473 mL in 1 BOTTLE (60575-414-16) |
NDC Information of Tricode
| NDC Code | 60575-414-16 |
| Proprietary Name | Tricode |
| Package Description | 473 mL in 1 BOTTLE (60575-414-16) |
| Product NDC | 60575-414 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Codeine Phosphate, Guaifenesin, Pseudoephedrine Hydrochloride |
| Dosage Form Name | LIQUID |
| Route Name | ORAL |
| Start Marketing Date | 20110620 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Respa Pharmaceuticals, Inc. |
| Substance Name | CODEINE PHOSPHATE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE |
| Strength Number | 8; 200; 30 |
| Strength Unit | mg/5mL; mg/5mL; mg/5mL |
| Pharmaceutical Classes |
